QNCX logo

Quince Therapeutics (QNCX) Company Overview

Profile

Full Name:

Quince Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 9, 2019

Indexes:

Not included

Description:

Quince Therapeutics (QNCX) is a biotechnology company focused on developing innovative therapies for rare diseases. They aim to improve patient outcomes through advanced drug discovery and development, targeting conditions with high unmet medical needs. Their research emphasizes precision medicine and personalized treatment approaches.

Events Calendar

Earnings

Next earnings date:

May 13, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 17, 2020
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 5, 25 D. Boral Capital
Buy
Jan 2, 25 D. Boral Capital
Buy
Dec 18, 24 Brookline Capital
Buy
Nov 14, 24 D. Boral Capital
Buy
Nov 12, 24 D. Boral Capital
Buy
Nov 7, 24 Maxim Group
Buy
Oct 29, 24 Rodman & Renshaw
Buy
Oct 22, 24 EF Hutton
Buy
May 11, 22 Credit Suisse
Underperform
Mar 9, 22 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Quince Therapeutics?
  • Does Quince Therapeutics pay dividends?
  • What sector is Quince Therapeutics in?
  • What industry is Quince Therapeutics in?
  • What country is Quince Therapeutics based in?
  • When did Quince Therapeutics go public?
  • Is Quince Therapeutics in the S&P 500?
  • Is Quince Therapeutics in the NASDAQ 100?
  • Is Quince Therapeutics in the Dow Jones?
  • When was Quince Therapeutics's last earnings report?
  • When does Quince Therapeutics report earnings?
  • Should I buy Quince Therapeutics stock now?

What is the ticker symbol for Quince Therapeutics?

The ticker symbol for Quince Therapeutics is NASDAQ:QNCX

Does Quince Therapeutics pay dividends?

No, Quince Therapeutics does not pay dividends

What sector is Quince Therapeutics in?

Quince Therapeutics is in the Healthcare sector

What industry is Quince Therapeutics in?

Quince Therapeutics is in the Biotechnology industry

What country is Quince Therapeutics based in?

Quince Therapeutics is headquartered in United States

When did Quince Therapeutics go public?

Quince Therapeutics's initial public offering (IPO) was on May 9, 2019

Is Quince Therapeutics in the S&P 500?

No, Quince Therapeutics is not included in the S&P 500 index

Is Quince Therapeutics in the NASDAQ 100?

No, Quince Therapeutics is not included in the NASDAQ 100 index

Is Quince Therapeutics in the Dow Jones?

No, Quince Therapeutics is not included in the Dow Jones index

When was Quince Therapeutics's last earnings report?

Quince Therapeutics's most recent earnings report was on Nov 13, 2024

When does Quince Therapeutics report earnings?

The next expected earnings date for Quince Therapeutics is May 13, 2025

Should I buy Quince Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions